Nick Leschly - Nov 6, 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Nov 6, 2024
Transactions value $
$0
Form type
4
Date filed
11/8/2024, 04:09 PM
Previous filing
Jan 9, 2024
Next filing
Jan 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +24.9K +8.56% $0.00 316K Nov 6, 2024 Direct F1
holding BLUE Common Stock 45.7K Nov 6, 2024 Nick Leschly 2001 Trust
holding BLUE Common Stock 123K Nov 6, 2024 Nick Leschly Irrevocable GST Trust of 2019

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +49.9K $0.00 49.9K Nov 6, 2024 Common Stock 49.9K $0.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.
F2 This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.